Ivenix
Amesbury, US · Delaware corporation · 1,812 employees on LinkedIn · 4 known investors
Ivenix makes an intelligent infusion pump system for hospital settings that delivers intravenous medications to patients while incorporating safeguards to reduce medication errors. The system is designed for nursing staff, pharmacists, IT departments, clinical engineers, and anesthesia professionals in healthcare facilities.
Founders & leadership
JS
John SokolowskiExecutive
GW
George W. GrayExecutive
CM
Carolyn MalleckExecutive
JA
Jesse AmbrosinaNamed on SEC filing
Board
KP
JK
WB
DJ
Darrell J. CrateBoard director
JM
John M. DouglassBoard director
CJ
Colin J. FosterBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$52.3M disclosed across 3 rounds · 2015–2017
▶$10MraisedMar 2017 · 18 investors · BiotechnologyRule 506(b)
▶$10MraisedMar 2017 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- George GrayExecutive Officer
- John ClarkeDirector
- John DouglassDirector
- Stuart RandleExecutive Officer, Director
- John WuDirector
- Jesse AmbrosinaExecutive Officer
- Ketan PatelDirector
- Wei LiDirector
- Offering amount
- $50M
- Amount sold
- $10M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$27.5MraisedSep 2015 · 25 investors · BiotechnologyRule 506(b)
▶$27.5MraisedSep 2015 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John SokolowskiExecutive Officer
- Darrell CrateDirector
- George GrayExecutive Officer
- John DouglassDirector
- Carolyn MalleckExecutive Officer
- Jesse AmbrosinaExecutive Officer
- Offering amount
- $27.5M
- Amount sold
- $27.5M
- Sales commissions
- $756.1K
- Placement agents
- Leerink Partners LLC
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14.8MraisedSep 2015 · 43 investors · BiotechnologyRule 506(b)
▶$14.8MraisedSep 2015 · 43 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ketan PatelDirector
- John M. DouglassDirector
- John SokolowskiExecutive Officer
- John K. ClarkeDirector
- Jesse AmbrosinaExecutive Officer
- Colin J. FosterDirector
- Wayne B. WeismanDirector
- Darrell J. CrateDirector
- George W. GrayExecutive Officer
- Carolyn MalleckExecutive Officer
- Offering amount
- $14.8M
- Amount sold
- $14.8M
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Ivenix do?
- Ivenix makes an intelligent infusion pump system for hospital settings that delivers intravenous medications to patients while incorporating safeguards to reduce medication errors. The system is designed for nursing staff, pharmacists, IT departments, clinical engineers, and anesthesia professionals in healthcare facilities.
- Who are Ivenix's investors?
- Ivenix's investors include Cardinal Partners, F-Prime Capital, SCP Vitalife Partners, ECO Fleet Holdings.
- How much funding has Ivenix raised?
- Ivenix has disclosed $52.3M raised across 3 rounds.
- Where is Ivenix headquartered?
- Ivenix is headquartered in Amesbury, US.